Structure |
Chemical Name |
CAS |
MF |
|
Nifekalant Impurity 8 |
|
|
|
Levosimendan Impurity 9 |
|
|
|
Cabozantinib impurity J |
|
|
|
Mixture of Pemetrexed disodium EP Impurity B and C |
|
|
|
Rotigotine Impurity 3 |
|
|
|
Crisaborole Impurity 5 |
2141947-89-7 |
C20H20BNO4 |
|
Crisaborole Impurity 10 |
|
|
|
1-(3-amino-4-(benzyloxy)phenyl)-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethan-1-ol |
345288-56-4 |
C25H30N2O3 |
|
Olprinone Impurity 4 |
|
|
|
Ribavirin Impurity 55 |
119240-35-6 |
C11H16O8 |
|
Cilastatin Impurity 4 |
|
|
|
Dyclonine Impurity 3 |
14146-86-2 |
C24H28O4 |
|
Brivaracetam Impurity F |
|
|
|
MeropeneM iMpurity 4 |
|
|
|
Perindopril IMpurity 4 |
|
|
|
Rupatadine Impurity 7 |
1704730-21-1 |
C26H26ClN3O |
|
ethyl 3-(dimethylamino)-2-(4-methoxyphenyl)propanoate hydrochloride |
2174001-92-2 |
C14H22ClNO3 |
|
Flucloxacillin Impurity 3 |
|
|
|
Nitrendipine iMpurity F |
|
|
|
Afatinib Impurity 52 |
|
|
|
Afatinib Impurity 67 |
|
|
|
Empagliflozin Impurity 60 |
|
|
|
Linagliptin Impurity 57 |
|
|
|
Linagliptin Impurity 62 |
|
|
|
Metronidazole Impurity 12 |
|
|
|
Nintedanib Impurity 36 |
|
|
|
Oseltamivir Impurity 47 |
|
|
|
Palbociclib Impurity 67 |
|
|
|
Pimecrolimus Impurity 3 |
|
|
|
Rosuvastatin Impurity 82 |
|
|
|
Tenofovir Impurity 76 |
|
|
|
Ticagrelor Impurity 125 |
|
|
|
Ticagrelor Impurity 39 |
|
|
|
Tofacitinib Impurity 109 |
|
|
|
Tofacitinib Impurity 114 |
|
|
|
Vildagliptin Impurity 34 |
1824265-77-1 |
C10H17NO3 |
|
1-(3-(benzyloxy)-5-hydroxyphenyl)-2-(tert-butylamino)ethan-1-one |
2459974-72-0 |
C19H23NO3 |
|
Demeclocycline EP Impurity C |
129044-45-7 |
C21H22N2O8 |
|
Brimonidine Impurity D |
|
|
|
Esmolol impurity D |
|
|
|
Diquafosol Impurity D |
|
|
|
Afatinib Impurity 10 |
|
|
|
Peramivir Impurity 11 |
|
|
|
Vildagliptin Impurity 6 |
|
|
|
Sunitinib Impurity 1 |
|
|
|
Erlotinib Impurity 18 |
|
|
|
Fasudil Impurity 6 |
1581642-06-9 |
C14H18ClN3O2S |
|
Rosuvastatin Impurity 56 |
|
|
|
Dapoxetine Impurity 4 |
|
|
|
Ticagrelor Impurity 17 |
|
|
|
Empagliflozin Impurity 13 |
|
|
|
Moxifloxacin Impurity 2 |
|
|
|
Cabozantinib Impurity 1 |
|
|
|
Febuxostat Impurity 56 |
|
|
|
Phosphine oxide, tris (2-methylphenyl)- |
6163-63-9 |
C21H21OP |
|
2-(7-Methoxynaphthalen-1-yl)acetamide |
138113-07-2 |
C13H13NO2 |
|
2-(2-carboxyethyl)-1-[(3,4-dimethoxyphenyl)methyl]-,1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium benzenesulfonate |
1075727-06-8 |
C30H37NO9S |
|
1,2,4-Triazolo[4,3-a]pyrazine, 7-[3-amino-1-oxo-4-(2,4,5-trifluorophenyl)-2-butenyl]-5,6,7,8-tetrahydro- 3-(trifluoromethyl)- |
847445-81-2 |
C16H13F6N5O |
|
4-Difluoromethoxy-2-nitro-aniline |
97963-76-3 |
C7H6F2N2O3 |
|
rac Des(isopropylaMino) Acebutolol Diol |
96480-91-0 |
C15H21NO5 |
|
(17α)-17-Hydroxy-3-oxo-19-norpregna-5(10),9(11)-diene-21-nitrile |
106111-42-6 |
C20H25NO2 |
|
(3S)-N-[[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]Methyl]-1-azabicyclo[2.2.2]octan-3-aMine |
177793-80-5 |
C18H26N2 |
|
4-(4-Fluorophenyl)-1-Methyl- |
1012886-75-7 |
C12H15ClFN |
|
5'(S)-Hydroxy SiMvastatin DISCONTINUED |
149949-05-3 |
C25H38O6 |
|
5'-Epi-LaMivudine |
136846-20-3 |
C8H11N3O3S |
|
N-ForMyl-D-ribofuranosyl-3-guanylurea (α/β-Mixture) |
686299-20-7 |
C8H14N4O6 |
|
SiMvastatin 4'-Methyl Ether |
864357-88-0 |
C26H40O5 |
|
(2S,3S,5S)-5-(tert-Butoxycarbonylamino)-2-(N-5-thiazolylmethoxycarbonyl)amino-1,6-diphenyl-3-hydroxyhexane |
162849-95-8 |
C28H35N3O5S |
|
4-DesMethoxy-4-broMo TriMethopriM |
16285-82-8 |
C13H15BrN4O2 |
|
Cefathiamidine Impurity D |
|
|
|
Cefazolin Impurity C (EP) |
|
|
|
Cefdinir Impurity H (CP) |
|
|
|
Cefdinir Impurity S(CP) |
|
|
|
Cefodizime oxidation Impurity 1 |
111874-11-4 |
C20H20N6O7S4 |
|
Spectinomycin Impurity F |
|
|
|
(7S,8R)-3-[2-(tert-butylamino)acetamido]-7-[[4-carbamoyl-2-(dimethylamino)-3,5,6-trihydroxyphenyl]methyl]-6-carboxy-5,8-dihydroxy-N,N-dimethyl-4-oxo-7,8-dihydronaphthalen-1(4H)-iminium |
|
C29H38N5O10+ |
|
3-pentylisobenzofuran-1(3H)-one |
111943-62-5 |
C13H16O2 |
|
2-[[2-2(2-Amino-4-thiazolyl)acetyl]amino]-4-thiazoleacetic Acid |
2036283-13-1 |
C10H10N4O3S2 |
|
Levofloxacin Impurity 18 |
138998-47-7 |
C14H13F4NO3 |
|
N-(5-amino-2-methylphenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)acetamide compound with methane (1:1) |
|
|
|
N-(2-methyl-5-(methylamino)phenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)formamide |
|
C18H17N5O |
|
methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate |
1616761-01-3 |
C17H23N5O3 |
|
Labetalol iMpurity |
2731858-23-2 |
|
|
ZXANKCFSGFEBQW-PFEQFJNWSA-N |
1258938-54-3 |
|
|
TWEORVZIMOFLDE-MXTNKPTQSA-N |
1706671-50-2 |
C25H31N5O9S |
|
WGEFOIHAXGTXJE-RTMVWDMESA-N |
1373171-12-0 |
C48H61NO14 |
|
ZIMIAPVHHUISPY-CLFYSBASSA-N |
866954-86-1 |
C15H15F3O5 |
|
Acyclovir Impurity 1 |
|
|
|
Ambroxol Impurity 9 HCl |
|
|
|
Penicillin Impurity A |
|
|
|
Cefminox Sodium impurity A |
|
|
|
Cefotiam Impurity A |
|
|
|
pranoprofen impurity 25 |
|
|
|
Flavomarein,2R-3',4',8-Trihydroxyflavanone-7-O-glucoside |
56389-87-8 |
C21H22O11 |
|
Peramivir Impurity D |
|
|
|
Lincomycin sulfoxide Impurity 2 |
|
|
|
Lincomycin sulfoxide Impurity E |
|
|
|
Fasudil iMpurity E |
|
|
|
(+/-)-EPINEPHRINE SULFONIC ACID |
26405-77-6 |
C9H13NO5S |
|
GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT) |
112188-16-6 |
C14H22GdN4O6 |